Low-dose propofol as a solo agent for sedation in postoperative ventilated liver transplant recipients: A preliminary observational study
Background and Aims: Propofol is a commonly used sedative agent, in a dose of 1.5-4.5 mg.kg-1.h-1. Following liver transplantation (LT), drug metabolism may be altered due to liver mass, altered hepatic blood flow, reduced levels of serum proteins, and liver regeneration. Thus, we hypothesized that...
Saved in:
Main Authors: | Rishabh Jaju (Author), Kelika Prakash (Author), M K Arora (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative evaluation of midazolam, dexmedetomidine, and propofol as Intensive Care Unit sedatives in postoperative electively ventilated eclamptic patients
by: Malik Rameez Rashid, et al.
Published: (2017) -
Remimazolam Tosylate Combined with Low-Dose Propofol Improves Sedation and Safety in Hysteroscopy
by: Zhang F, et al.
Published: (2022) -
Pharmacodynamic modeling of moderate sedation and rationale for dosing using midazolam, propofol and alfentanil
by: Jing-Yang Liou, et al.
Published: (2023) -
Outcomes When Using Adjunct Dexmedetomidine with Propofol Sedation in Mechanically Ventilated Surgical Intensive Care Patients
by: Jessica M. Louie, et al.
Published: (2018) -
Midazolam/fentanyl vs. propofol/remifentanil in immediate postoperative with short-term mechanical ventilation
by: José Domingo López Castilla, et al.
Published: (2022)